Monday, September 29, 2008
|
08:00 |
Welcome and Opening Remarks |
|
Device Therapeutics |
|
|
08:10 |
Device Therapeutic Research at Sunnybrook |
|
08:15 |
Device Therapeutic Research at Robarts |
|
08:20 |
Imaging for Management of Chronic Total Occlusions |
|
08:40 |
Active Visualization of MR-Compatible Guidewires |
|
08:50 |
Cardiac MRI in Electrophysiological Procedures and Device Therapy |
|
09:10 |
Towards a Medical Augmented Reality Environment for Minimally Invasive Cardiac Surgery and Therapy |
|
09:20 |
Discussion |
|
09:30 |
Poster Viewing and Coffee Break |
|
Myocardial Therapeutics |
|
|
10:00 |
Using Gene Expression for MRI Contrast: MagA versus Ferritin |
|
10:20 |
Towards SPECT Imaging of Transplanted Cell Survival in Canine Myocardium |
|
10:30 |
PET imaging for the evaluation of tissue engineering and cell therapy in heart repair |
|
10:50 |
Myocardial Perfusion Measurement by Prospective ECG-Gated Dynamic CT Scanning |
|
Vascular Therapeutics |
|
|
11:00 |
MRI of the Vulnerable Plaque |
|
11:20 |
Quantification of Carotid Atherosclerosis using 3D Ultrasound Images |
|
11:30 |
Vulnerable Plaque Imaging |
|
11:50 |
Development and Validation of Novel MR Contrast Agents for Atherosclerotic Plaque Imaging |
|
Noon |
Lunch |
